Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by 20/20 Biolabs Inc.

News headline image
20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand
From 20/20 Biolabs Inc.
Via GlobeNewswire
Tickers AIDX
News headline image
20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress
From 20/20 Biolabs Inc.
Via GlobeNewswire
Tickers AIDX
News headline image
20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina
From 20/20 Biolabs Inc.
Via GlobeNewswire
Tickers AIDX
News headline image
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
From 20/20 Biolabs Inc.
Via GlobeNewswire
Tickers AIDX
News headline image
20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress
From 20/20 Biolabs Inc.
Via GlobeNewswire
Tickers AIDX
News headline image
Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test
From 20/20 Biolabs Inc.
Via GlobeNewswire
Tickers AIDX
News headline image
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program
From 20/20 Biolabs Inc.
Via GlobeNewswire
Tickers AIDX
News headline image
20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies
From 20/20 Biolabs Inc.
Via GlobeNewswire
Tickers AIDX
News headline image
20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities
From 20/20 Biolabs Inc.
Via GlobeNewswire
Tickers AIDX
News headline image
20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time
From 20/20 Biolabs Inc.
Via GlobeNewswire
Tickers AIDX
News headline image
20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth
From 20/20 Biolabs Inc.
Via GlobeNewswire
Tickers AIDX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.